Related Experiment Video
Updated: Mar 9, 2026

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
Published on: December 20, 2019
Morvan syndrome associated with prominent Tau pathology: A clinicopathological case report
Gary Álvarez Bravo1, Rosa Ferrer Tarrés2, Andreu Vilaseca Jolonch3
1Neuroimmunology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona/Salt, Spain; Neurodegeneration and Neuroinflammation Research Group, Biomedical Research Institute of Girona (IDIBGI), Salt, Spain; Neurology Department, Doctor Josep Trueta University Hospital, Spain; Department of Medical Sciences, University of Girona, Girona, Spain; Cooperative Research Networks Oriented to Health Outcomes (RICORS), Inflammatory Diseases Network (RD21/0002/0063), Carlos III Health Institute, Madrid, Spain.
Introduction:
We report a case of Morvan syndrome in a 48-year-old man, emphasizing the presence of prominent tau pathology in the frontal cortex identified during postmortem examination. Morvan syndrome is characterized by peripheral nerve hyperexcitability, autonomic dysfunction, and encephalopathy, and is often associated with antibodies against LGI1 and Caspr2.
Methods:
Clinical assessment documented neurological, autonomic, and cognitive symptoms consistent with Morvan syndrome. Serological testing confirmed LGI1 and Caspr2 antibodies. Despite treatment, the patient suffered fatal cardiac arrest. Full autopsy, including detailed neuropathological assessment, was performed, with specific examination of neuronal and glial tau pathology.
Results:
Autopsy revealed a thymoma and extensive tau accumulation in the frontal cortex with neuronal and astrocytic involvement. Neurofibrillary tangles, pretangles, and astroglial tau aggregates were detected. The patient had no history of repetitive head trauma or participation in contact sports.
Conclusions:
This case suggests a potential association between immune-mediated disorders-specifically Morvan syndrome with LGI1 and Caspr2 antibodies-and focal tau pathology. The coexistence of autoimmune features and tau deposition raises questions about shared or interacting pathophysiological mechanisms. Further research is warranted to clarify these relationships.
Insights
This case study reveals tau pathology in the brain of a patient with Morvan syndrome, an autoimmune disorder. The findings suggest a link between autoimmune conditions and tau accumulation, warranting further investigation.
Area of Science:
- Neurology
- Immunology
- Pathology
Background:
- Morvan syndrome is an autoimmune disorder characterized by peripheral nerve hyperexcitability, autonomic dysfunction, and encephalopathy.
- It is often associated with antibodies against LGI1 and Caspr2.
- This case highlights a patient with Morvan syndrome and concurrent tau pathology.
Purpose of the Study:
- To report a case of Morvan syndrome with prominent tau pathology.
- To investigate the neuropathological findings in a fatal case of Morvan syndrome.
- To explore the potential association between autoimmune disorders and tau deposition.
Main Methods:
- Clinical assessment of neurological, autonomic, and cognitive symptoms.
- Serological testing for LGI1 and Caspr2 antibodies.
- Postmortem neuropathological examination focusing on tau pathology in the frontal cortex.
Main Results:
- Autopsy revealed thymoma and extensive tau accumulation in the frontal cortex, involving neurons and astrocytes.
- Neurofibrillary tangles, pretangles, and astroglial tau aggregates were identified.
- The patient had no history of head trauma or contact sports.
Conclusions:
- This case suggests a potential association between Morvan syndrome (LGI1/Caspr2 antibodies) and focal tau pathology.
- The coexistence of autoimmune features and tau deposition raises questions about shared pathophysiological mechanisms.
- Further research is needed to clarify the relationship between autoimmune disorders and tauopathies.
Related Concept Videos
Neural Regulation
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Aneurysm II: Clinical Manifestations and Diagnostic Studies

